Queen's Awards Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

OSU-T315 (15-regioisomer)

SKU: orb1220931

Description

OSU-T315 (15-regioisomer) is a ILK inhibitor.

Images & Validation

Key Properties

CAS Number2070015-22-2
MW533.6
Purity>98% (HPLC)
FormulaC30H30F3N5O
SMILESCNC(=O)CCc1cc(nn1-c1ccc(cc1)N1CCNCC1)-c1ccc(cc1)-c1ccc(cc1)C(F)(F)F
TargetIntegrin
SolubilityDMSO:50 mg/mL (93.70 mM)

Bioactivity

In Vivo
OSU-T315 (Oral gavage; 25 mg/kg, 50 mg/kg; single daily; 35 days) has a suppressive effect of on PC-3 xenograft tumor growth. No other obvious toxicity is observed in mice. Animal model: Male NCr athymic nude mice with PC-3 tumor xenografts. Dosage: 25 mg/kg; 50 mg/kg. Administration: Oral gavage; single daily; 35 days. Result: Resulted in suppression of tumor growth relative to the vehicle control after 35 days of treatment (48% and 62% suppression for 25 and 50 mg/kg, respectively).
In Vitro
OSU-T315 (Compound 22; 0-5 μM; 24 hours) exhibits high in vitro potency against a panel of prostate and breast cancer cell lines with a IC50 range of 1-2.5 μM. OSU-T315 (0-2.5 μM; 24 hours) can reduce YB-1, HER2, and EGFR expression; shows a modest suppressive effect on phosphorylated S6 levels, exhibits dose-dependent suppressive effects on the levels of phospho-ERK1/2 and phospho-p38, while that of phospho-JNK remains unaltered in PC-3 cell. OSU-T315 (0-4 μM; 24 hours) causes autophagy through ILK inhibition. Western blot analysis. Cell line: PC-3 cells; MDA-MB-231 cells. Concentration: 1 μM, 2 μM, 3 μM, 4 μM; 0.5 μM, 1 μM, 1.5 μM, 2 μM, 2.5 μM Incubation time: 24 hours. Result: Exhibited a dose-dependent decreasing effect on the phosphorylation of pS6, ERKs, and p38 in PC-3 cells and MDA-MB-231 cells. Cell Viability Assay Cell line: Prostate cancer cells: LNCaP, PC-3; breast cancer cells: MDA-MB-231, MDA-MB-468, SKBR3, MCF-7; PrEC and MEC cells. Concentration: 0-5 μM. Incubation time: 24 hours. Result: Suppressed cancer cells viability in breast and prostate cancer cells (IC (50), 1-2.5 μM). Apoptosis Analysis. Cell line: PC-3 cells. Concentration: 1 μM, 2 μM, 3 μM, 4 μM. Incubation time: 24 hours. Result: Induced accumulation of LC3-II and PARP cleavage.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

ILK-IN-2
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

OSU-T315 (15-regioisomer) (orb1220931)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

2 mg
$ 220.00
5 mg
$ 350.00
10 mg
$ 540.00
25 mg
$ 900.00
50 mg
$ 1,270.00
100 mg
$ 1,680.00
500 mg
$ 3,380.00